Business Context and Reporting Period
Purple Biotech Ltd., a foreign private issuer based in Rehovot, Israel, filed this Form 6-K on June 26, 2024. The filing serves as a notice regarding the scheduling of the Company's Annual General Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing.
Guidance, Outlook, and Corporate Actions
The primary purpose of this filing is to announce the Annual General Meeting of Shareholders, scheduled for Thursday, August 8, 2024, at 4:30 p.m. Israel time. The meeting will be held at the Company's offices at 4 Oppenheimer Street, Science Park, Rehovot, Israel. The filing incorporates the Notice of Annual General Meeting, Proxy Statement, and Voting Slip (Exhibit 99.1), as well as the BNY Mellon Voting Instruction Form for American Depositary Shareholders (Exhibit 99.2). The Company notes that information on its website does not constitute part of this Form 6-K.
Key Facts for Investor Verification
- Verify the date and time of the Annual General Meeting: August 8, 2024, at 4:30 p.m. Israel time.
- Confirm the location of the meeting: 4 Oppenheimer Street, Science Park, Rehovot, Israel.
- Review the attached Proxy Statement (Exhibit 99.1) for specific agenda items and voting proposals.
- Check the BNY Mellon Voting Instruction Form (Exhibit 99.2) if holding American Depositary Shares.
- Note that this filing contains no financial performance data or forward-looking guidance.